Clinical trial
Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
NCT00040638 is registered in ClinicalTrials.gov with Telik as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
- Lead sponsor
- Telik
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- August 31, 2003
- Enrollment
- 40
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.